hydroxyurea has been researched along with hydroxychloroquine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Aboulhab, J; Karim, F; Paton, NI | 1 |
| Aboulhab, J; Paton, NI | 1 |
| Anderson, EJ; Edara, VV; Grubbs, G; Khurana, S; Lapp, SA; Patel, PA; Pauly, MG; Piantadosi, A; Rostad, CA; Sabnis, HS; Stokes, CL; Suthar, MS | 1 |
1 review(s) available for hydroxyurea and hydroxychloroquine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for hydroxyurea and hydroxychloroquine
| Article | Year |
|---|---|
Hydroxychloroquine, hydroxyurea and didanosine as initial therapy for HIV-infected patients with low viral load: safety, efficacy and resistance profile after 144 weeks.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Hydroxychloroquine; Hydroxyurea; Male; Mutation; Treatment Outcome; Viral Load | 2005 |
4 other study(ies) available for hydroxyurea and hydroxychloroquine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Hydroxychloroquine+ddI+Hydroxyurea antiretroviral trial, AIDS Research Alliance, Los Angeles.
Topics: Anti-HIV Agents; Antimalarials; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Hydroxychloroquine; Hydroxyurea; Los Angeles; Nucleic Acid Synthesis Inhibitors; Patient Selection | 1999 |
Hydroxychloroquine, hydroxycarbamide, and didanosine as economic treatment for HIV-1.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Enzyme Inhibitors; Female; HIV Infections; HIV-1; Humans; Hydroxychloroquine; Hydroxyurea; Male; Pilot Projects; Treatment Outcome; Viral Load | 2002 |
Immune responses and therapeutic challenges in paediatric patients with new-onset acute myeloid leukaemia and concomitant COVID-19.
Topics: Adenosine Monophosphate; Adolescent; Alanine; Antimalarials; Antineoplastic Agents; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Disease Management; Humans; Hydroxychloroquine; Hydroxyurea; Leukemia, Myeloid, Acute; Male; SARS-CoV-2; Young Adult | 2021 |